• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CAN
Click for more information
0.00% 6.2¢

CANN GROUP LIMITED - Corporate Spotlight

Market Cap $27.12M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare

Cann Group Limited is an Australia-based company that is focused on developing,... Cann Group Limited is an Australia-based company that is focused on developing, producing, and supplying innovative cannabis medicines. The principal activities of the Company include the cultivation of medicinal cannabis for both medicinal and research purposes pursuant to the licenses and permits issued to the group, the development and manufacture (via third party arrangements) of finished product formulations, and the pursuit and execution of various supply agreements with third parties. The Company supplies a range of dried flower and oil products, as well as active pharmaceutical ingredients and extracts, to customers in Australia and around the world. It also owns Satipharm and its patent-protected capsule technology. The Company's research, cultivation and good manufacturing practices (GMP) manufacturing facilities are located in Melbourne, and a cultivation and GMP manufacturing facility is near Mildura, Victoria.More

No Corporate Spotlight currently available.

(20min delay)
Last
6.2¢ 		Change
0.000(0.00%) 		Mkt cap ! $27.12M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
CAN (ASX) Chart

Top Stories

Patagonia shares rise above 20% on lithium grades at maiden well in Argentina

Patagonia Lithium shares rise above 12 percent on lithium grading nearly 600 parts per million at the first drill well of its Argentinian Formentera Lithium Project.
Macquarie profits fall 32% on 'market volatility' and low-achieving 'green investments' Macquarie Bank has shaved more than 30 percent off its net profit in the final quarter of the 2024 financial year (FY 2024), compared to the same time last year, with executives speaking cautiously about market volatility and @lower asset realisations’ from green investments, but ...
Why Princeton Professor rates BlinkLab's autism & ADHD screening app In this interview with Sonia Madigan, Professor Sam Wang of Princeton University discusses the development and potential of BlinkLab's (ASX:BB1) AI-driven smartphone app, designed to screen for autism and ADHD.
Dancing to that same 70s tune, China, and why I'm backing gold It is too early to judge what concrete measures the Future Made in Australia policy will entail. However, any policy which has a stated aim to screen qualifying capital for suitability at a government level, does not seem like a strong signal for foreigners to get on a plane, come visit some mine sites and invest.
Infini Resources gearing up for UAV geophys survey over Portland Creek Infini Resources has announced its execution of an application for UAV-based geophysical surveys over its Portland Creek Uranium Project.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.